DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. $(GILD)$ advanced 1.47% to $115.99 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.76% to 5,849.72 and Dow Jones Industrial Average falling 1.48% to 43,191.24.
This was the stock's third consecutive day of gains.
Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $114.77, which the company reached on February 28th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ rose 1.37% to $167.28, Pfizer Inc. $(PFE)$ fell 0.68% to $26.25, and Abbott Laboratories $(ABT)$ rose 1.60% to $140.22.
Trading volume (10.0 M) eclipsed its 50-day average volume of 7.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 03, 2025 16:36 ET (21:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。